MIRANDA AKERS: Open Payments
NPI 1275138612 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 17 payments from 12 companies in 2025. Trend: 2023 $175 · 2024 $207 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $81 |
| PFIZER INC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $28 |
| Exelixis Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| SOBI, INC | 1 | $18 |
Products named: DAXXIFY, Nubeqa, DATROWAY, ELAHERE, XTANDI, OJJAARA, CABOMETYX, PADCEV.
Industry payments across MO — which companies pay providers there.
